Bergeron J, Ammirati M, Danley D, James L, Norcia M, Retsema J, Strick C A, Su W G, Sutcliffe J, Wondrack L
Central Research Division, Pfizer Inc., Groton, Connecticut 06340, USA.
Antimicrob Agents Chemother. 1996 Sep;40(9):2226-8. doi: 10.1128/AAC.40.9.2226.
N,N-dimethylglycylamido (DMG) derivatives of 6-demethyl-6-deoxytetracycline and doxycycline bind 5-fold more effectively than tetracycline to the tetracycline high-affinity binding site on the Escherichia coli 70S ribosome, which correlates with a 10-fold increase in potency for inhibition of E. coli cell-free translation. The potencies of DMG-doxycycline and DMG-6-demethyl-6-deoxytetracycline were unaffected by the ribosomal tetracycline resistance factors Tet(M) and Tet(O) in cell-free translation assays and whole-cell bioassays with a conditional Tet(M)-producing E. coli strain.
6-去甲基-6-脱氧四环素和强力霉素的N,N-二甲基甘氨酰胺(DMG)衍生物与四环素相比,与大肠杆菌70S核糖体上的四环素高亲和力结合位点的结合效率高5倍,这与抑制大肠杆菌无细胞翻译的效力提高10倍相关。在无细胞翻译试验以及使用条件性产生Tet(M)的大肠杆菌菌株进行的全细胞生物测定中,DMG-强力霉素和DMG-6-去甲基-6-脱氧四环素的效力不受核糖体四环素抗性因子Tet(M)和Tet(O)的影响。